Artwork

Content provided by PER Spectives and PER® Spectives. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PER Spectives and PER® Spectives or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

S1 Ep6: Tumor Board: Bridging Current Practices and New Therapeutic Developments in ER-Positive Breast Cancer

49:22
 
Share
 

Manage episode 333680684 series 2987803
Content provided by PER Spectives and PER® Spectives. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PER Spectives and PER® Spectives or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
During this educational Tumor Board, breast cancer specialists will showcase challenging scenarios in metastatic and non-metastatic HR+ disease and contextualize data from pivotal clinical trials to optimize decision-making for patients with HR+/HER2- breast cancer.
Featuring:
Fátima Cardoso, MD
Director, Breast Unit
Champalimaud Clinical Center
Lisbon, Portugal

Mario Campone, MD, PhD
Chief Executive Officer
Institut de Cancérologie de l’Ouest (ICO)
Angers, France

Giuseppe Viale, MD, FRCPath
Chairman
Department of Pathology
University of Milan
Milan, Italy
  continue reading

42 episodes

Artwork
iconShare
 
Manage episode 333680684 series 2987803
Content provided by PER Spectives and PER® Spectives. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PER Spectives and PER® Spectives or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
During this educational Tumor Board, breast cancer specialists will showcase challenging scenarios in metastatic and non-metastatic HR+ disease and contextualize data from pivotal clinical trials to optimize decision-making for patients with HR+/HER2- breast cancer.
Featuring:
Fátima Cardoso, MD
Director, Breast Unit
Champalimaud Clinical Center
Lisbon, Portugal

Mario Campone, MD, PhD
Chief Executive Officer
Institut de Cancérologie de l’Ouest (ICO)
Angers, France

Giuseppe Viale, MD, FRCPath
Chairman
Department of Pathology
University of Milan
Milan, Italy
  continue reading

42 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play